Page last updated: 2024-08-23

piperacillin and ro13-9904

piperacillin has been researched along with ro13-9904 in 79 studies

Research

Studies (79)

Timeframe	Studies, this research(%)	All Research%
pre-1990	15 (18.99)	18.7374
1990's	10 (12.66)	18.2507
2000's	23 (29.11)	29.6817
2010's	22 (27.85)	24.3611
2020's	9 (11.39)	2.80

Authors

Authors	Studies
Hanberger, H; Isaksson, B; Maller, R; Nilsson, LE; Nilsson, M	1
Aksebzeci, T; Fazli, SA	1
Marie, JP; Thevenin, D; Zittoun, R	1
Casali, W; Cogo, R; Fraschini, F; Ripamonti, L; Scaglione, F	1
Braveny, I; Machka, K; Röbl, M	1
Fontana, R; Gesu, GP; Maresu, F; Rossi, L; Satta, G; Stefani, S	1
Brasch, H; Iven, H	1
Cantoni, E; Galletti, R; Giannelli, G; Mincione, E; Tassinari, M	1
Bosso, JA; Marble, DA; Townsend, RJ	1
Falcidia, A; Mirone, L; Salvo, S	1
Brom, A; Eckert, P; Schneider, G	1
Hoogkamp-Korstanje, JA	1
Asphaug Kjellevold, V; Dibb, WL; Digranes, A	1
Dietz, R; Machka, K	1
Jones, R; Satishchandran, V; Shapiro, T; Suh, B; Truant, AL	1
Appelbaum, PC; Jacobs, MR; Pankuch, GA	1
Edelstein, MA; Edelstein, PH	1
Spencer, RC	1
Aldridge, KE; Johnson, WD	1
Hanberger, H; Nilsson, LE	1
Büyükpamukçu, N; Ciftci, AO; Hiçsonmez, A; Tanyel, FC	1
Verbist, L; Verhaegen, J	1
Chang, MH; Cho, YS; Choi, KI; Ha, YJ; Koh, HY; Kwon, JS; Lee, GS; Pae, AN; Yoon, CM	1
Anastasio, P; Casoli, E; De Santo, NG; Molino, D	1
Amato, R; Andò, F; Azzaro, R; Bellissima, P; Cicciarella, S; Covelli, I; Delia, S; Fogliani, V; Fraschini, F; Girbino, G; Jacoviello, C; Laganà, P; Magrì, M; Maierna, G; Maria, GD; Marone, P; Messina, G; Muscianisi, G; Napoletano, G; Pela, R; Pezza, A; Rizza, S; Rossi, A; Sabato, V; Sanguinetti, C; Tedeschi, D; Varotto, F; Viola, B; Vitale, S	1
Chen, M; Xu, Y; Zhang, S	1
Friedland, I; Majumdar, A; Mixson, LA; Motyl, M; Woods, GL	1
Fixson, A; Glasmacher, A; Gorschlüter, M; Hahn, C; Horré, R; Marklein, G; Mey, U; Molitor, E; Sauerbruch, T; Schmidt-Wolf, IG; Ziske, C	1
Gesser, RM; McCarroll, K; Teppler, H; Woods, GL	1
Carmeli, Y; Gold, HS; Graham, CS; Sands, BE; Schwaber, MJ	1
Bonet, A; García-Oria, M; Rodríguez, I; Rodríguez, JI; Roig, J; Sirvent, JM	1
Kitazato, M; Minami, S; Mitsuyama, J; Mizunaga, S; Morikawa, Y; Watanabe, Y	1
Friedland, IR; Gesser, RM; Herman, G; Isaacs, R; Meibohm, A; Mistry, G; Teppler, H; Woods, GL	1
Azanza, JR; Campanero, MA; García-Quetglas, E; Sádaba, B	1
Helfand, MS; Hutton-Thomas, R; Lakticová, V; Rice, LB	1
Giltri, G; Isella, M; Larocca, A; Marinoni, S; Miccolis, I; Parma, M; Pogliani, EM; Rossini, F; Terruzzi, E; Verga, L	1
Dias, MA; Konefal, SH; McLaughlin, MR; Wadie, GM	1
Chan, CY; Dinubile, MJ; Friedland, I; Giezek, H; Motyl, MR; Quinn, JP; Shivaprakash, M; Weinstein, RA	1
Gatti, M; Piscolla, F; Varoli, O	1
Diridl, G; Jeschko, E; Pichler, H; Wolf, D	1
Carreras, E; Fernández-Avilés, F; Gallego, C; García, L; Gaya, A; González, M; Granell, M; Hernando, A; Martínez, C; Montserrat, E; Ramiro, L; Rovira, M; Segura, S; Urbano-Ispizua, A; Valverde, M	1
Donskey, CJ; Pultz, NJ; Stiefel, U	1
Borbone, S; Cascone, C; Mezzatesta, ML; Santagati, M; Stefani, S	1
Chan, MR; Pirsch, JD	1
Khan, HM; Malik, A; Shahid, M; Shujatullah, F; Shukla, I; Singhai, M; Tahira, F	1
Donskey, CJ; Pultz, MJ	1
Aronowitz, P; London, V	1
Chang, KT; Ledesma, KR; Quinn, JP; Tam, VH; Wang, TY	1
Garratty, G	2
Bellón, T; Bobolea, ID; Cabañas, R; Fiandor-Román, AM; Jurado-Palomo, J; López-Serrano, MC; Prior, N; Quirce, S	1
Braun, L; Fairchok, M; Flanagan, R; Mahlen, S; Sainato, R	1
Altunsoy, A; Aypak, C; Azap, A; Balık, I; Ergönül, Ö	1
Bak, N; Holds, JM; Papanicolas, LE	1
Alba, LR; Jia, H; Kubin, CJ; Yoko Furuya, E	1
Hsueh, PR; Lee, YT; Tsao, SM	1
Feizabadi, MM; Ghodousi, A; Haeili, M; Nomanpour, B; Omrani, M	1
Calvo, G; Llauradó-Serra, M; Martín-Loeches, I; Pontes, C; Soy, D; Ulldemolins, M; Vaquer, S	1
Baek, JY; Chung, DR; Huh, K; Kang, CI; Kim, YS; Ko, KS; Lee, NY; Peck, KR; Sohn, KM; Song, JH	1
Athan, E; Baker, P; Harris, PN; Harris-Brown, T; Ingram, PR; Iredell, J; Lipman, J; McBryde, ES; Miyakis, S; Paterson, DL; Paul, SK; Peleg, AY; Roberts, JA; Rogers, BA; Stewardson, AJ	1
Hong, MT; Seifert, CF	1
Baines, C; Brown, B; Lewis, I; Smart, D	1
Gholipourmalekabadi, M; Hashemi, A; Mozafari, M; Rostami, A; Sameni, M; Zamani, F	1
Deis, AS; Simpson, SQ; Whiles, BB	1
García Carretero, R; Lopez-Lomba, M; Rodriguez-Maya, B; Vazquez-Gomez, O	1
Bailoor, K; Chen, T	1
Fusco, NM; Hassinger, AB; Holsen, MR; Meaney, CJ	1
Heather, CS; Maley, M	1
Ally, M; Briscoe, S; Lipman, J; McWhinney, B; Roberts, JA; Ungerer, J; Wong, G	1
Al Khamis, M; Alenazi, TH; Arabi, Y; Athan, E; Baker, P; Bassetti, M; Beatson, SA; Bhally, H; Boyles, TH; Crowe, A; Daneman, N; Falcone, M; Griffin, P; Harris, PNA; Harris-Brown, T; Ingram, P; Iredell, J; Kanj, S; Lee, TH; Looke, D; Lorenc, P; Lye, DC; Mendelson, M; Miyakis, S; Mo, Y; Paterson, DL; Peleg, AY; Righi, E; Roberts, L; Rogers, BA; Tambyah, PA; Walls, G; Yilmaz, M; Zikri, A	1
Asai, N; Hagihara, M; Kato, H; Koizumi, Y; Mikamo, H; Ohashi, W; Sakanashi, D; Shibata, Y; Shiota, A; Suematsu, H; Watanabe, H; Yamagishi, Y	1
Sun, J; Xie, L; Xu, R; Zhu, D	1
Hiort, B; Hofmann, M; Hopf, HB; Kehmann, J; Kim, SH; Starl, A	1
Baklouti, S; De Riols, P; Gandia, P; Garrigues, JC; Lanot, T; Lavit, M; Mané, C; Ruiz, S; Seraissol, P	1
Al Atbee, MYN; Jalil, MB	1
Cottrell, K; Harris, PNA; Heffernan, AJ; Lipman, J; Naicker, S; Roberts, JA; Sime, FB; Sumi, CD; Wallis, SC	1
Arenere-Mendoza, M; Fernández-de-Gamarra-Martínez, E; Fernández-Polo, A; González-Suárez, S; Gutiérrez-Urbón, JM; Nicolás-Picó, J; Rodríguez-Mateos, ME; Sánchez-Yáñez, E	1
Bautista, J; Beique, L; Cayen, J; Choi, K; Comeau, JL; Conly, J; Dalton, B; Delport, J; Dhami, R; Embree, J; Émond, Y; Evans, G; Frenette, C; Fryters, S; Happe, J; Katz, K; Kibsey, P; Langley, JM; Lee, BE; Lefebvre, MA; Leis, JA; McGeer, A; McKenna, S; Neville, HL; Pelude, L; Rudnick, W; Science, M; Slayter, K; Suh, KN; Thirion, DJG; Tse-Chang, A; Weiss, K	1
Abdulla, A; Bahmany, S; Ewoldt, TMJ; Koch, BCP	1

Reviews

3 review(s) available for piperacillin and ro13-9904

Article	Year
Safety and tolerability of ertapenem. The Journal of antimicrobial chemotherapy, 2004, Volume: 53 Suppl 2 Topics: Adult; Aged; Anti-Bacterial Agents; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; beta-Lactams; Ceftriaxone; Clinical Trials as Topic; Community-Acquired Infections; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Randomized Controlled Trials as Topic	2004
Immune hemolytic anemia caused by drugs. Expert opinion on drug safety, 2012, Volume: 11, Issue:4 Topics: Anemia, Hemolytic, Autoimmune; Cefotetan; Ceftriaxone; Coombs Test; Humans; Piperacillin	2012
Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy. Critical care (London, England), 2014, Jun-23, Volume: 18, Issue:3 Topics: Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Critical Illness; Humans; Meropenem; Piperacillin; Renal Replacement Therapy; Shock, Septic; Thienamycins	2014

Trials

10 trial(s) available for piperacillin and ro13-9904

Article	Year
[Comparative evaluation of the in vitro and in vivo antibacterial activity of ceftriaxone and piperacillin: determination of the inhibitory quotient in bronchial secretions]. Recenti progressi in medicina, 1988, Volume: 79, Issue:5 Topics: Aged; Bacteria; Bronchi; Bronchitis; Ceftriaxone; Clinical Trials as Topic; Haemophilus influenzae; Humans; Injections, Intramuscular; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Random Allocation; Streptococcus pneumoniae	1988
Comparative trial of four antibiotic combinations for perforated appendicitis in children. The European journal of surgery = Acta chirurgica, 1997, Volume: 163, Issue:8 Topics: Adolescent; Amebicides; Anti-Bacterial Agents; Antibiotic Prophylaxis; Appendicitis; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Clindamycin; Drug Therapy, Combination; Female; Humans; Injections, Intravenous; Intestinal Perforation; Male; Ornidazole; Penicillins; Piperacillin; Prospective Studies; Rupture, Spontaneous; Tobramycin; Treatment Outcome	1997
Piperacillin-tazobactam is more effective than ceftriaxone plus gentamicin in febrile neutropenic patients with hematological malignancies: a randomized comparison. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2003, Volume: 11, Issue:6 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Ceftriaxone; Cost-Benefit Analysis; Drug Therapy, Combination; Enzyme Inhibitors; Female; Fever; Gentamicins; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Penicillins; Piperacillin; Tazobactam; Treatment Outcome	2003
Efficacy of ertapenem in the treatment of serious infections caused by Enterobacteriaceae: analysis of pooled clinical trial data. The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:5 Topics: Adult; Aged; beta-Lactams; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Double-Blind Method; Drug Therapy, Combination; Enterobacteriaceae Infections; Ertapenem; Escherichia coli Infections; Humans; Lactams; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Tazobactam; Treatment Outcome; Urinary Tract Infections	2003
[Randomized, prospective and comparative clinical trial of piperacillin/tazobactam versus ceftriaxone plus ornidazole in the treatment of biliary tract infections]. Medicina clinica, 2003, Dec-06, Volume: 121, Issue:20 Topics: Aged; Anti-Bacterial Agents; Bile Duct Diseases; Ceftriaxone; Female; Humans; Infections; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prospective Studies	2003
A randomized clinical trial of ceftriaxone and amikacin versus piperacillin tazobactam and amikacin in febrile patients with hematological neoplasia and severe neutropenia. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2005, Volume: 13, Issue:6 Topics: Adult; Aged; Amikacin; Anti-Bacterial Agents; Ceftriaxone; Drug Therapy, Combination; Female; Fever; Hematologic Neoplasms; Humans; Male; Middle Aged; Neutropenia; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Treatment Outcome	2005
Bowel colonization with resistant gram-negative bacilli after antimicrobial therapy of intra-abdominal infections: observations from two randomized comparative clinical trials of ertapenem therapy. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2005, Volume: 24, Issue:7 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Carrier State; Ceftriaxone; Digestive System Surgical Procedures; Drug Resistance, Bacterial; Drug Therapy, Combination; Ertapenem; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Intestines; Lactams; Male; Metronidazole; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2005
Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2006, Oct-20, Volume: 24, Issue:30 Topics: Adult; Aged; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antineoplastic Agents, Alkylating; Busulfan; Ceftriaxone; Female; Fever; Health Care Costs; Hematologic Neoplasms; Home Care Services; Hospital Charges; Humans; Inpatients; Male; Middle Aged; Neutropenia; Patient Readmission; Penicillanic Acid; Piperacillin; Stem Cell Transplantation; Tazobactam; Transplantation, Autologous	2006
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trial. Trials, 2015, Jan-27, Volume: 16 Topics: Adult; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Clinical Protocols; Drug Resistance, Microbial; Escherichia coli Infections; Humans; Klebsiella Infections; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sample Size; Thienamycins	2015
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial. JAMA, 2018, 09-11, Volume: 320, Issue:10 Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Cause of Death; Ceftriaxone; Drug Resistance, Bacterial; Escherichia coli; Escherichia coli Infections; Female; Humans; Klebsiella Infections; Klebsiella pneumoniae; Male; Meropenem; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins	2018

Other Studies

66 other study(ies) available for piperacillin and ro13-9904

Article	Year
Synergistic post-antibiotic effect of amikacin and beta-lactam antibiotics on Enterococcus faecalis. The Journal of antimicrobial chemotherapy, 1991, Volume: 27 Suppl C Topics: Amikacin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Drug Synergism; Drug Therapy, Combination; Endocarditis, Bacterial; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Piperacillin; Streptococcal Infections	1991
[Susceptibility of clinically-isolated problem pathogenic bacteria to broad spectrum antibiotics]. Mikrobiyoloji bulteni, 1989, Volume: 23, Issue:4 Topics: Amikacin; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacteria; Ceftriaxone; Clavulanic Acids; Drug Therapy, Combination; Enterobacter; Escherichia coli; Humans; Klebsiella; Netilmicin; Piperacillin; Proteus; Pseudomonas; Staphylococcus	1989
[In vitro inhibition of granulopoiesis by beta-lactam antibiotics. Comparison of piperacillin, mezlocillin, ceftriaxone and ceftazidime]. Presse medicale (Paris, France : 1983), 1986, Dec-20, Volume: 15, Issue:46 Topics: Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Female; Granulocytes; Hematopoiesis; Humans; Male; Mezlocillin; Piperacillin	1986
Comparison of the serum bactericidal activity of ceftriaxone/piperacillin and ceftriaxone/netilmicin. European journal of clinical microbiology, 1986, Volume: 5, Issue:1 Topics: Ceftriaxone; Drug Evaluation; Drug Synergism; Enterobacteriaceae; Humans; Netilmicin; Piperacillin; Pseudomonas aeruginosa; Staphylococcus aureus	1986
Different activity of penicillins and cephalosporins on enterococci. Chemioterapia : international journal of the Mediterranean Society of Chemotherapy, 1987, Volume: 6, Issue:2 Suppl Topics: Ampicillin; Ceftazidime; Ceftriaxone; Cephalosporins; Enterococcus faecalis; Humans; Microbial Sensitivity Tests; Penicillins; Piperacillin; Streptococcus	1987
The effects of antibiotics and uricosuric drugs on the renal elimination of methotrexate and 7-hydroxymethotrexate in rabbits. Cancer chemotherapy and pharmacology, 1988, Volume: 21, Issue:4 Topics: Animals; Anti-Bacterial Agents; Benzbromarone; Ceftriaxone; Furosemide; Kidney; Metabolic Clearance Rate; Methotrexate; Piperacillin; Probenecid; Rabbits; Sulfamethoxazole; Sulfinpyrazone; Uricosuric Agents	1988
[Clinico-statistical observations on the use of ceftriaxone (rocefin) in dental practice and maxillofacial surgery]. Minerva stomatologica, 1987, Volume: 36, Issue:4 Topics: Adolescent; Adult; Aged; Ceftriaxone; Child; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Ketoprofen; Male; Middle Aged; Mouth Diseases; Piperacillin; Surgery, Oral	1987
Stability of clindamycin phosphate with aztreonam, ceftazidime sodium, ceftriaxone sodium, or piperacillin sodium in two intravenous solutions. American journal of hospital pharmacy, 1986, Volume: 43, Issue:7 Topics: Aztreonam; Ceftazidime; Ceftriaxone; Clindamycin; Drug Stability; Hydrogen-Ion Concentration; Injections, Intravenous; Piperacillin; Solutions; Temperature	1986
[Comparative study of the in vitro activity of 5 new antibiotics on strains isolated from urinary infections]. Minerva medica, 1987, Jan-31, Volume: 78, Issue:2 Topics: Cefotaxime; Ceftazidime; Ceftriaxone; Humans; Microbial Sensitivity Tests; Netilmicin; Piperacillin; Urinary Tract Infections	1987
[Perioperative antibiotic prophylaxis. A comparative study of 244 patients with colonic diseases]. Wiener medizinische Wochenschrift. Supplement, 1985, Volume: 87 Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Colonic Diseases; Colonic Neoplasms; Female; Humans; Male; Metronidazole; Middle Aged; Piperacillin; Premedication; Risk; Surgical Wound Infection	1985
Activity of cefotaxime and ceftriaxone alone and in combination with penicillin, ampicillin and piperacillin against neonatal meningitis pathogens. The Journal of antimicrobial chemotherapy, 1985, Volume: 16, Issue:3 Topics: Ampicillin; Cefotaxime; Ceftriaxone; Drug Combinations; Drug Interactions; Escherichia coli; Humans; Infant, Newborn; Listeria monocytogenes; Meningitis; Microbial Sensitivity Tests; Penicillins; Piperacillin; Streptococcus agalactiae	1985
Pseudomonas aeruginosa and Acinetobacter calcoaceticus: in vitro susceptibility of 150 clinical isolates to five beta-lactam antibiotics and tobramycin. Chemotherapy, 1983, Volume: 29, Issue:5 Topics: Acinetobacter; Anti-Bacterial Agents; Azlocillin; Carbenicillin; Cefotaxime; Ceftriaxone; Penicillin Resistance; Penicillins; Piperacillin; Pseudomonas aeruginosa; Thienamycins; Tobramycin	1983
Comparative synergistic activity of ceftriaxone-piperacillin versus ceftriaxone-netilmicin. European journal of clinical microbiology, 1983, Volume: 2, Issue:5 Topics: Cefotaxime; Ceftriaxone; Dose-Response Relationship, Drug; Drug Synergism; Enterobacteriaceae; Gentamicins; Microbial Sensitivity Tests; Netilmicin; Piperacillin; Pseudomonas aeruginosa	1983
In vitro activity of beta-lactamase inhibitors against clinical isolates of Acinetobacter species. Diagnostic microbiology and infectious disease, 1995, Volume: 21, Issue:2 Topics: Acinetobacter; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamase Inhibitors; Cefotaxime; Ceftazidime; Ceftriaxone; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Imipenem; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sensitivity and Specificity; Sulbactam; Tazobactam	1995
Susceptibilities of 200 penicillin-susceptible and -resistant pneumococci to piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, ceftazidime, and ceftriaxone. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:12 Topics: Ampicillin; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Clavulanic Acids; Microbial Sensitivity Tests; Penicillanic Acid; Penicillin Resistance; Piperacillin; Streptococcus pneumoniae; Sulbactam; Tazobactam; Ticarcillin	1994
In vitro extracellular and intracellular activities of clavulanic acid and those of piperacillin and ceftriaxone alone and in combination with tazobactam against clinical isolates of Legionella species. Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:2 Topics: Animals; Ceftriaxone; Cells, Cultured; Clavulanic Acid; Clavulanic Acids; Drug Interactions; Drug Therapy, Combination; Extracellular Space; Guinea Pigs; Intracellular Fluid; Legionella; Legionella pneumophila; Legionnaires' Disease; Macrophages, Alveolar; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Tazobactam	1994
Cross-susceptibility of cefpirome and four other beta-lactams against isolates from haematology/oncology and intensive care units. International Study Group. Scandinavian journal of infectious diseases. Supplementum, 1993, Volume: 91 Topics: Anti-Bacterial Agents; Bacterial Infections; Cefpirome; Ceftazidime; Ceftriaxone; Cephalosporins; Cross Infection; Drug Resistance, Microbial; Europe; Gram-Negative Bacteria; Gram-Positive Bacteria; Hospital Units; Humans; Imipenem; Intensive Care Units; Microbial Sensitivity Tests; Piperacillin; Prevalence	1993
A comparison of susceptibility results of the Bacteroides fragilis group and other anaerobes by traditional MIC results and statistical methods. The Journal of antimicrobial chemotherapy, 1997, Volume: 39, Issue:3 Topics: Bacteria, Anaerobic; Bacteroides; Bacteroides fragilis; beta-Lactam Resistance; Cefotaxime; Cefoxitin; Ceftizoxime; Ceftriaxone; Cephalosporins; Clindamycin; Clostridium; Drug Resistance, Microbial; Eubacterium; Metronidazole; Microbial Sensitivity Tests; Penicillins; Peptostreptococcus; Piperacillin; Prevotella; Veillonella	1997
[A multicenter study shows alarming results. High antibiotic resistance within Swedish intensive care]. Lakartidningen, 1997, Jun-18, Volume: 94, Issue:25 Topics: Anti-Bacterial Agents; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Resistance, Multiple; Gram-Negative Bacteria; Humans; Intensive Care Units; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Sweden	1997
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. The Journal of antimicrobial chemotherapy, 1998, Volume: 41, Issue:3 Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae	1998
Synthesis and evaluation of 2 beta-oxyimino and alkenylpenicillanic acid sulfone derivatives as beta-lactamase inhibitors. Archiv der Pharmazie, 1999, Volume: 332, Issue:1 Topics: beta-Lactamase Inhibitors; Ceftriaxone; Cephalosporins; Citrobacter freundii; Drug Synergism; Enzyme Inhibitors; Microbial Sensitivity Tests; Penicillanic Acid; Penicillins; Piperacillin; Sulfones	1999
Renal abscess: recovery without hospitalization and drainage. Clinical nephrology, 2001, Volume: 56, Issue:2 Topics: Abscess; Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Drainage; Female; Hospitalization; Humans; Kidney; Kidney Diseases; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Radiography; Staphylococcal Infections; Ultrasonography	2001
An observational study on the epidemiology of respiratory tract bacterial pathogens and their susceptibility to four injectable beta-lactam antibiotics: piperacillin, piperacillin/tazobactam, ceftazidime and ceftriaxone. Journal of chemotherapy (Florence, Italy), 2001, Volume: 13, Issue:4 Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Disease Susceptibility; Female; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Multicenter Studies as Topic; Penicillanic Acid; Piperacillin; Respiratory Tract Infections; Tazobactam	2001
[Multicenter evaluation of the antimicrobial activity in vitro for six broad-spectrum beta-lactams in China using the E-test method]. Zhonghua yi xue za zhi, 2000, Volume: 80, Issue:5 Topics: Anti-Bacterial Agents; Bacteria; beta-Lactams; Cefepime; Cefoperazone; Ceftazidime; Ceftriaxone; Cephalosporins; China; Imipenem; Microbial Sensitivity Tests; Piperacillin	2000
In vitro activity of ertapenem against common clinical isolates in relation to human pharmacokinetics. Journal of chemotherapy (Florence, Italy), 2002, Volume: 14, Issue:5 Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Ceftriaxone; Community-Acquired Infections; Drug Resistance, Microbial; Drug Therapy, Combination; Enterobacteriaceae; Ertapenem; Haemophilus influenzae; Humans; Lactams; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Staphylococcus aureus; Streptococcus agalactiae; Streptococcus pyogenes	2002
Treatment with a broad-spectrum cephalosporin versus piperacillin-tazobactam and the risk for isolation of broad-spectrum cephalosporin-resistant Enterobacter species. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:6 Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Ceftazidime; Ceftriaxone; Cohort Studies; Drug Therapy, Combination; Enterobacter; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Multivariate Analysis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proportional Hazards Models; Retrospective Studies; Risk Factors	2003
In vitro activities of piperacillin against beta-lactamase-negative ampicillin-resistant Haemophilus influenzae. Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:4 Topics: Ampicillin Resistance; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefotaxime; Ceftriaxone; Cephalosporins; Haemophilus influenzae; Hexosyltransferases; Humans; Kinetics; Meningitis, Haemophilus; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Penicillins; Peptidyl Transferases; Piperacillin	2004
Relationship between pharmacokinetics and pharmacodynamics of beta-lactams and outcome. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2004, Volume: 10, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Cefepime; Ceftriaxone; Cephalosporins; Female; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Treatment Outcome	2004
In vitro antienterococcal activity explains associations between exposures to antimicrobial agents and risk of colonization by multiresistant enterococci. The Journal of infectious diseases, 2004, Dec-15, Volume: 190, Issue:12 Topics: Animals; Anti-Bacterial Agents; Carrier State; Ceftriaxone; Colony Count, Microbial; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance, Multiple, Bacterial; Enterococcus faecium; Feces; Female; Gastrointestinal Tract; Gram-Positive Bacterial Infections; Mice; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2004
Cervical spondylodiscitis from an ingested pin: a case report. Journal of pediatric surgery, 2005, Volume: 40, Issue:3 Topics: Accidents; Adolescent; Amoxicillin-Potassium Clavulanate Combination; Antibiotic Prophylaxis; Bone Plates; Ceftriaxone; Cervical Vertebrae; Clindamycin; Combined Modality Therapy; Deglutition Disorders; Discitis; Diskectomy; Emergencies; Equipment Contamination; Follow-Up Studies; Foreign Bodies; Humans; Laryngoscopy; Larynx; Male; Neck Pain; Oxacillin; Paresthesia; Penicillanic Acid; Pharynx; Piperacillin; Piperacillin, Tazobactam Drug Combination; Radiography; Recurrence; Retropharyngeal Abscess; Spinal Fusion; Vancomycin; Wounds, Penetrating	2005
In vitro study of the antibacterial activity of cefotetan compared with piperacillin and ceftriaxone against bacterial strains isolated from pathological material of hospital patients. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefotetan; Ceftriaxone; Humans; Inpatients; Microbial Sensitivity Tests; Piperacillin	1989
Ceftriaxone vs. piperacillin in patients with bacterial meningitis. Journal of chemotherapy (Florence, Italy), 1989, Volume: 1, Issue:4 Suppl Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Controlled Clinical Trials as Topic; Humans; Meningitis, Bacterial; Piperacillin; Treatment Outcome	1989
Effect of carbapenem administration on establishment of intestinal colonization by vancomycin-resistant enterococci and Klebsiella pneumoniae in mice. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:1 Topics: Animals; beta-Lactams; Carbapenems; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Enterococcus; Ertapenem; Female; Imipenem; Intestines; Klebsiella pneumoniae; Mice; Piperacillin; Sodium Chloride; Time Factors; Vancomycin Resistance	2007
Bactericidal activity of ertapenem against major intra-abdominal pathogens. International journal of antimicrobial agents, 2006, Volume: 28, Issue:5 Topics: Abdomen; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; beta-Lactams; Ceftazidime; Ceftriaxone; Digestive System Diseases; Enterobacter cloacae; Enterococcus faecalis; Ertapenem; Escherichia coli; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Klebsiella; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Proteus mirabilis; Staphylococcus aureus; Time Factors	2006
Nonserogroup O1 Vibrio cholerae in a renal transplant patient. Transplantation, 2007, Mar-15, Volume: 83, Issue:5 Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Cholera; Ciprofloxacin; Humans; Kidney Transplantation; Male; Piperacillin; Reoperation; Treatment Outcome; Vibrio cholerae O1	2007
In vitro efficacy of ceftriaxone/sulbactam against Escherichia coli isolates producing CTX-M-15 extended-spectrum beta-lactamase. The Journal of antimicrobial chemotherapy, 2007, Volume: 60, Issue:1 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; beta-Lactamases; Ceftriaxone; Drug Combinations; Drug Synergism; Enzyme Inhibitors; Escherichia coli; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Sulbactam; Tazobactam	2007
Effects of imipenem-cilastatin, ertapenem, piperacillin-tazobactam, and ceftriaxone treatments on persistence of intestinal colonization by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae strains in mice. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:8 Topics: Animals; Anti-Bacterial Agents; beta-Lactamases; Ceftriaxone; Cilastatin; Cilastatin, Imipenem Drug Combination; Drug Combinations; Humans; Imipenem; Intestines; Klebsiella Infections; Klebsiella pneumoniae; Mice; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2007
Purpuric rash of meningococcemia. Journal of hospital medicine, 2008, Volume: 3, Issue:2 Topics: Anti-Infective Agents; Anti-Inflammatory Agents; Bacteremia; Ceftriaxone; Humans; Hydrocortisone; Male; Meningococcal Infections; Middle Aged; Neisseria meningitidis; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Protein C; Purpura; Recombinant Proteins; Vancomycin	2008
Killing of Escherichia coli by beta-lactams at different inocula. Diagnostic microbiology and infectious disease, 2009, Volume: 64, Issue:2 Topics: Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Ceftriaxone; Colony Count, Microbial; Ertapenem; Escherichia coli; Humans; Microbial Viability; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors	2009
Drug-induced immune hemolytic anemia. Clinical advances in hematology & oncology : H&O, 2010, Volume: 8, Issue:2 Topics: Anemia, Hemolytic; Anti-Bacterial Agents; Antineoplastic Agents; Cefotetan; Ceftriaxone; Coombs Test; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Piperacillin; Vidarabine	2010
Use of the lymphocyte transformation test in the diagnosis of DRESS syndrome induced by ceftriaxone and piperacillin-tazobactam: two case reports. Journal of investigational allergology & clinical immunology, 2010, Volume: 20, Issue:5 Topics: Adrenal Cortex Hormones; Adult; Anticonvulsants; beta-Lactams; Ceftriaxone; Cell Proliferation; Cells, Cultured; Colitis, Ulcerative; Drug Hypersensitivity; Eosinophilia; Epilepsy; Exanthema; Female; Histamine Antagonists; Humans; Lymphocyte Activation; Male; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2010
Severe human parechovirus sepsis beyond the neonatal period. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2011, Volume: 51, Issue:1 Topics: Anti-Bacterial Agents; Blood Coagulation Disorders; Ceftriaxone; Enterocolitis, Necrotizing; Enzyme Inhibitors; Fever; Heart Failure; Hepatitis; Humans; Infant; Male; Parechovirus; Penicillanic Acid; Picornaviridae Infections; Piperacillin; Respiratory Insufficiency; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Sepsis; Sequence Analysis, RNA; Tazobactam	2011
The impact of a nationwide antibiotic restriction program on antibiotic usage and resistance against nosocomial pathogens in Turkey. International journal of medical sciences, 2011, Volume: 8, Issue:4 Topics: Acinetobacter; Anti-Bacterial Agents; Cefepime; Ceftazidime; Ceftriaxone; Cephalosporins; Cost Savings; Cross Infection; Drug Costs; Drug Prescriptions; Drug Resistance, Bacterial; Drug Utilization; Escherichia; Health Policy; Hospitals; Humans; Imipenem; Klebsiella; Meropenem; Methicillin Resistance; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas; Staphylococcus aureus; Teicoplanin; Thienamycins; Turkey; Vancomycin	2011
Meningitis and pneumonitis caused by pet rodents. The Medical journal of Australia, 2012, Feb-20, Volume: 196, Issue:3 Topics: Adult; Animals; Anti-Bacterial Agents; C-Reactive Protein; Ceftriaxone; Ciprofloxacin; Female; Fusobacterium Infections; Humans; Hypoxia; Meningitis, Bacterial; Penicillanic Acid; Pets; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Rats; Respiratory Distress Syndrome; Streptobacillus; Thrombocytopenia	2012
Lack of significant variability among different methods for calculating antimicrobial days of therapy. Infection control and hospital epidemiology, 2012, Volume: 33, Issue:4 Topics: Adult; Anti-Infective Agents; Ceftriaxone; Drug Dosage Calculations; Humans; Kidney Diseases; Ofloxacin; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Time Factors; Tobramycin; Vancomycin	2012
Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2013, Volume: 32, Issue:9 Topics: Acinetobacter baumannii; Acinetobacter Infections; Aged; Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Cilastatin; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Female; Humans; Imipenem; Male; Minocycline; Piperacillin; Sulbactam; Tigecycline; Treatment Outcome	2013
Drug resistance patterns of bacteria isolated from patients with nosocomial pneumonia at Tehran hospitals during 2009-2011. Journal of infection in developing countries, 2013, Apr-17, Volume: 7, Issue:4 Topics: Acinetobacter baumannii; Anti-Bacterial Agents; Ceftriaxone; Cross Infection; Drug Resistance, Multiple, Bacterial; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Hospitals; Humans; Iran; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Bacterial; Polymyxin B; Prevalence; Pseudomonas aeruginosa; Respiratory Tract Infections; Sputum; Staphylococcus aureus	2013
A new causative bacteria of infective endocarditis, Bergeyella cardium sp. nov. Diagnostic microbiology and infectious disease, 2015, Volume: 81, Issue:3 Topics: Adult; Anti-Bacterial Agents; Ceftriaxone; Cluster Analysis; DNA, Bacterial; DNA, Ribosomal; Endocarditis; Flavobacteriaceae; Hospitals; Humans; Korea; Male; Microbial Sensitivity Tests; Middle Aged; Molecular Sequence Data; Penicillanic Acid; Phylogeny; Piperacillin; Piperacillin, Tazobactam Drug Combination; RNA, Ribosomal, 16S; Sequence Analysis, DNA; Treatment Outcome	2015
Clinical Impact of Discordant Prescribing of Fluoroquinolones and Alternative Treatments in Escherichia coli Pyelonephritis. Journal of pharmacy practice, 2016, Volume: 29, Issue:5 Topics: Adult; Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Drug Resistance, Bacterial; Escherichia coli Infections; Female; Fluoroquinolones; Guidelines as Topic; Humans; Length of Stay; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pyelonephritis; Retrospective Studies; Treatment Outcome	2016
Performance of the Baxter Infusor LV10 under hyperbaric conditions. Diving and hyperbaric medicine, 2015, Volume: 45, Issue:1 Topics: Anti-Bacterial Agents; Ceftriaxone; Dopamine; Elastomers; Hyperbaric Oxygenation; Infusion Pumps; Infusions, Intravenous; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Temperature; Time Factors; Vancomycin	2015
Silver- and fluoride-containing mesoporous bioactive glasses versus commonly used antibiotics: Activity against multidrug-resistant bacterial strains isolated from patients with burns. Burns : journal of the International Society for Burn Injuries, 2016, Volume: 42, Issue:1 Topics: Amikacin; Animals; Anti-Bacterial Agents; Aztreonam; Burns; Carbenicillin; Cefepime; Ceftazidime; Ceftriaxone; Cell Survival; Cephalosporins; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Fluorides; Gentamicins; Glass; Humans; Imipenem; Meropenem; Mice; Microbial Sensitivity Tests; NIH 3T3 Cells; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pseudomonas aeruginosa; Silver; Thienamycins; Tobramycin; Wound Infection	2016
Increased Time to Initial Antimicrobial Administration Is Associated With Progression to Septic Shock in Severe Sepsis Patients. Critical care medicine, 2017, Volume: 45, Issue:4 Topics: Adult; Aged; Anti-Bacterial Agents; Ceftriaxone; Comorbidity; Disease Progression; Female; Hospital Mortality; Humans; Length of Stay; Levofloxacin; Male; Middle Aged; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Sepsis; Sex Factors; Shock, Septic; Time Factors; Time-to-Treatment; Vasoconstrictor Agents	2017
Bacteraemia and liver abscess due to BMJ case reports, 2017, Jul-27, Volume: 2017 Topics: Abdominal Pain; Anti-Bacterial Agents; Bacteremia; Ceftriaxone; Fusobacterium Infections; Fusobacterium necrophorum; Humans; Liver Abscess; Male; Metronidazole; Middle Aged; Nausea; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sepsis; Treatment Outcome; Vomiting	2017
Fungating groin mass in a woman with a history of follicular lymphoma. BMJ case reports, 2017, Aug-16, Volume: 2017 Topics: Anti-Bacterial Agents; Antineoplastic Agents; Ceftriaxone; Cyclophosphamide; Diagnosis, Differential; Escherichia coli Infections; Female; Groin; Humans; Lymphoma, Follicular; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Penicillanic Acid; Piperacillin; Positron-Emission Tomography; Rituximab; Tazobactam; Tomography, X-Ray Computed; Vincristine	2017
Increased Risk of Acute Kidney Injury in Critically Ill Children Treated With Vancomycin and Piperacillin/Tazobactam. Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies, 2017, Volume: 18, Issue:12 Topics: Acute Kidney Injury; Adolescent; Anti-Bacterial Agents; Ceftriaxone; Child; Child, Preschool; Critical Illness; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Infant; Intensive Care Units, Pediatric; Logistic Models; Male; Odds Ratio; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Vancomycin	2017
Automated direct screening for resistance of Gram-negative blood cultures using the BD Kiestra WorkCell. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2018, Volume: 37, Issue:1 Topics: Ampicillin; Anti-Bacterial Agents; Bacteremia; Blood Culture; Ceftriaxone; Ciprofloxacin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Bacterial; Gentamicins; Gram-Negative Bacteria; Humans; Meropenem; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Thienamycins	2018
Therapeutic drug monitoring of β-lactam antibiotics in the critically ill: direct measurement of unbound drug concentrations to achieve appropriate drug exposures. The Journal of antimicrobial chemotherapy, 2018, 11-01, Volume: 73, Issue:11 Topics: Adult; Aged; Anti-Bacterial Agents; beta-Lactams; Ceftriaxone; Critical Illness; Drug Monitoring; Female; Humans; Logistic Models; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Piperacillin; Prospective Studies; Treatment Outcome	2018
Ceftriaxone versus tazobactam/piperacillin and carbapenems in the treatment of aspiration pneumonia: A propensity score matching analysis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2021, Volume: 27, Issue:10 Topics: Anti-Bacterial Agents; Carbapenems; Ceftriaxone; Humans; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Pneumonia, Aspiration; Propensity Score; Retrospective Studies	2021
Emerging resistance to ceftriaxone treatment owing to different ampD mutations in Enterobacter roggenkampii. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2022, Volume: 102 Topics: Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Ceftriaxone; Drug Resistance, Bacterial; Enterobacter; Enterobacter cloacae; Humans; Liver Abscess; Microbial Sensitivity Tests; Mutation; Piperacillin; Tazobactam	2022
[Personalized intensive care medicine : Implementation of therapeutic drug monitoring to assess antibiotic levels in intensive care patients]. Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2023, Volume: 118, Issue:3 Topics: Anti-Bacterial Agents; Ceftazidime; Ceftriaxone; Critical Care; Drug Monitoring; Humans; Meropenem; Piperacillin; Retrospective Studies; Tigecycline	2023
Evaluation of 4 quantification methods for monitoring 16 antibiotics and 1 beta-lactamase inhibitor in human serum by high-performance liquid chromatography with tandem mass spectrometry detection. Journal of pharmaceutical and biomedical analysis, 2022, Sep-20, Volume: 219 Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cefepime; Ceftriaxone; Chromatography, High Pressure Liquid; Chromatography, Liquid; Ciprofloxacin; Humans; Piperacillin; Reproducibility of Results; Tandem Mass Spectrometry	2022
The prevalence of multiple drug resistance Escherichia coli and Klebsiella pneumoniae isolated from patients with urinary tract infections. Journal of clinical laboratory analysis, 2022, Volume: 36, Issue:9 Topics: Ampicillin; Anti-Bacterial Agents; Aztreonam; Cefepime; Ceftazidime; Ceftriaxone; Ciprofloxacin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Infections; Gentamicins; Humans; Imipenem; Klebsiella Infections; Klebsiella pneumoniae; Levofloxacin; Microbial Sensitivity Tests; Piperacillin; Prevalence; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections	2022
Pharmacodynamic evaluation of intermittent versus extended and continuous infusions of piperacillin/tazobactam in a hollow-fibre infection model against Escherichia coli clinical isolates. The Journal of antimicrobial chemotherapy, 2022, 10-28, Volume: 77, Issue:11 Topics: Anti-Bacterial Agents; Ceftriaxone; Escherichia coli; Escherichia coli Infections; Humans; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination	2022
PAUSATE Study: Prevalence and appropriateness of the use of antimicrobials in Spanish hospitals. Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, 2022, 08-02, Volume: 46, Issue:5 Topics: Anti-Bacterial Agents; Anti-Infective Agents; Ceftriaxone; Clavulanic Acid; Cross-Sectional Studies; Hospitals; Humans; Meropenem; Piperacillin; Prevalence; Tazobactam	2022
Antimicrobial use among paediatric inpatients at hospital sites within the Canadian Nosocomial Infection Surveillance Program, 2017/2018. Antimicrobial resistance and infection control, 2023, 04-18, Volume: 12, Issue:1 Topics: Adult; Anti-Infective Agents; Canada; Cefazolin; Ceftriaxone; Child; Cross Infection; Hospitals; Humans; Infant, Newborn; Inpatients; Piperacillin; Tazobactam	2023
Stability of 10 Beta-Lactam Antibiotics in Human Plasma at Different Storage Conditions. Therapeutic drug monitoring, 2023, 10-01, Volume: 45, Issue:5 Topics: Amoxicillin; Anti-Bacterial Agents; Cefotaxime; Ceftazidime; Ceftriaxone; Cefuroxime; Floxacillin; Humans; Imipenem; Meropenem; Monobactams; Piperacillin; Tandem Mass Spectrometry	2023